Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tahir Latif

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Pancreas|July 14, 2020
Patterns of Failure After Neoadjuvant Stereotactic Body Radiation Therapy or Fractionated Chemoradiation in Resectable and Borderline Resectable Pancreatic CancerMichelle Barrord, Syed Ahmad, Sameer Patel, et al.
Toxicology Research|July 29, 2025
Development of an epitope-based vaccine from <i>mycoplasma genitalium</i> adhesion protein: addressing antibiotic resistance through immune-informaticsHafiz Muhammad Rehman, Muhammad Bilal, Muhammad Shoaib, et al.
American Journal of Clinical Oncology|February 7, 2019
Pattern of Marginal Local Failure in a Phase II Trial of Neoadjuvant Chemotherapy and Stereotactic Body Radiation Therapy for Resectable and Borderline Resectable Pancreas CancerJordan Kharofa, Michelle Mierzwa, Olugbenga Olowokure, et al.
Surgery|October 17, 2017
Downstaging therapy followed by liver transplantation for hepatocellular carcinoma beyond Milan criteriaYoung Kim, Christopher C Stahl, Abouelmagd Makramalla, et al.
Blood Advances|August 31, 2022
Rational polypharmacological targeting of FLT3, JAK2, ABL, and ERK1 suppresses the adaptive resistance to FLT3 inhibitors in AMLMohammad Azhar, Zachary Kincaid, Meenu Kesarwani, et al.
Nature Medicine|March 21, 2017
Targeting c-FOS and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemiaMeenu Kesarwani, Zachary Kincaid, Ahmed Gomaa, et al.
Nature Medicine|April 17, 2023
Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trialZachary D Crees, Michael P Rettig, Reyka G Jayasinghe, et al.
JAMA Oncology|August 17, 2023
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19Shuchi Gulati, Chih-Yuan Hsu, Surbhi Shah, et al.
Blood Cancer Discovery|March 9, 2022
Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19Samuel M Rubinstein, Divaya Bhutani, Ryan C Lynch, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Pancreas|July 14, 2020
Patterns of Failure After Neoadjuvant Stereotactic Body Radiation Therapy or Fractionated Chemoradiation in Resectable and Borderline Resectable Pancreatic CancerMichelle Barrord, Syed Ahmad, Sameer Patel, et al.
Toxicology Research|July 29, 2025
Development of an epitope-based vaccine from <i>mycoplasma genitalium</i> adhesion protein: addressing antibiotic resistance through immune-informaticsHafiz Muhammad Rehman, Muhammad Bilal, Muhammad Shoaib, et al.
American Journal of Clinical Oncology|February 7, 2019
Pattern of Marginal Local Failure in a Phase II Trial of Neoadjuvant Chemotherapy and Stereotactic Body Radiation Therapy for Resectable and Borderline Resectable Pancreas CancerJordan Kharofa, Michelle Mierzwa, Olugbenga Olowokure, et al.
Surgery|October 17, 2017
Downstaging therapy followed by liver transplantation for hepatocellular carcinoma beyond Milan criteriaYoung Kim, Christopher C Stahl, Abouelmagd Makramalla, et al.
Blood Advances|August 31, 2022
Rational polypharmacological targeting of FLT3, JAK2, ABL, and ERK1 suppresses the adaptive resistance to FLT3 inhibitors in AMLMohammad Azhar, Zachary Kincaid, Meenu Kesarwani, et al.
Nature Medicine|March 21, 2017
Targeting c-FOS and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemiaMeenu Kesarwani, Zachary Kincaid, Ahmed Gomaa, et al.
Nature Medicine|April 17, 2023
Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trialZachary D Crees, Michael P Rettig, Reyka G Jayasinghe, et al.
JAMA Oncology|August 17, 2023
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19Shuchi Gulati, Chih-Yuan Hsu, Surbhi Shah, et al.
Blood Cancer Discovery|March 9, 2022
Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19Samuel M Rubinstein, Divaya Bhutani, Ryan C Lynch, et al.
Pageof 2